Symbol="ZLAB"
AssetType="Common Stock"
Name="Zai Lab Ltd"
Description="Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops and markets therapies to treat cancer, autoimmune and infectious diseases in China. The company is headquartered in Shanghai, China."
CIK="1704292"
Exchange="NASDAQ"
Currency="USD"
Country="China"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4560 JINKE ROAD, BLDG. 1, 4F, PUDONG, SHANGHAI, CHINA"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="2391897000"
EBITDA="-385892992"
PERatio="None"
PEGRatio="None"
BookValue="9.63"
DividendPerShare="0"
DividendYield="0"
EPS="-4.22"
RevenuePerShareTTM="2.619"
ProfitMargin="-1.561"
OperatingMarginTTM="-1.568"
ReturnOnAssetsTTM="-0.196"
ReturnOnEquityTTM="-0.366"
RevenueTTM="251801000"
GrossProfitTTM="-145386000"
DilutedEPSTTM="-4.22"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.429"
AnalystTargetPrice="72.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="17.13"
PriceToBookRatio="3.106"
EVToRevenue="12.53"
EVToEBITDA="-4.723"
Beta="1.087"
num_52WeekHigh="53.95"
num_52WeekLow="20.98"
num_50DayMovingAverage="27.33"
num_200DayMovingAverage="33.6"
SharesOutstanding="98839000"
DividendDate="None"
ExDividendDate="None"
symbol="ZLAB"
open="24.55"
high="24.91"
low="23.79"
price="24.20"
volume="286195.00"
latest_trading_day="2023-08-24"
previous_close="24.38"
change="-0.18"
change_percent="-0.7383%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="533766"
Change_recent_avg="-0.19"
Delta_recent_avg="1.51"
Variance_recent_avg="0.76"
Change_ratio_recent_avg="-0.7"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="95"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_negative_thumbnail_id_2="136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_neutral_thumbnail_id_1="557"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_neutral_thumbnail_id_2="575"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_positive_thumbnail_id_1="599"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0109.jpeg"
image_positive_thumbnail_id_2="966"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0128.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
